Abstract
ABSTRACT Benjamin Schumann is a Group Leader at the Francis Crick Institute and a Senior Lecturer in Chemical Biology at Imperial College London, UK. His research focuses on developing precision tools to advance the field of glycobiology and study of the roles of sugars in human health and disease. After completing his undergraduate and doctoral studies in Germany in biochemistry and synthetic chemistry, he moved to Stanford University in California, USA. There, he used bioorthogonal ‘click chemistry’ techniques to understand some of the intricacies of glycobiology. In 2018, he established his independent lab in the UK, where he leads an interdisciplinary group combining organic synthesis methods with cutting-edge quantitative biology to study glycans in various model systems. We spoke with Ben to learn more about how he found the ‘sweet spot’ for his career, his approaches to scientific mentorship and why more biologists should pay attention to glycans.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
